MukoCell

About:

MukoCell GmbH is a pharmaceutical company with headquarters in the German city of Dortmund.

Website: https://mukocell.com/en/

Twitter/X: cellmuko

Top Investors: EASME - EU Executive Agency for SMEs

Description:

MukoCell GmbH is a pharmaceutical company with headquarters in the German city of Dortmund. Complying with current Good Manufacturing Practices (GMP), MukoCell GmbH delivers products of extreme safety and quality. Their company has patented technologies in the growing field of tissue engineering, where the patient’s own cells are used in the treatment of his or her urological disorder. Current indications for the first product developed by their company include the repair of urethral strictures and hypospadias. Patients have the option of urethral reconstruction with an autologous MukoCell® cell transplant since 2010. Urethral repair with MukoCell® is a gentle alternative to conventional transplantation with native buccal mucosa.

Total Funding Amount:

2.63M EUR

Headquarters Location:

Dortmund, Nordrhein-Westfalen, Germany

Founded Date:

2013-01-01

Contact Email:

info(AT)mukocell.com

Founders:

Gouya Ram-Liebig, Sören Liebig

Number of Employees:

1-10

Last Funding Date:

2018-08-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai